Autism & I/DD

Intellectual and developmental disabilities (I/DD) are a physical and/or cognitive impairments that occur before the age of 22. Autism spectrum disorder is generally considered a type of developmental disability that affects behaviour and communication. The autism and I/DD market provides supports and health care services to these populations. Over the past decade, there has been an increase in the changes and challenges affecting I/DD and autism markets—the move to managed care and value-based care, the shift away from residential treatment, the increasing emphasis on consumer-directed care, and new workforce challenges.

Latest Resources

• Behavioral Health Network Opens New Autism Support Centers In Springfield & Fall River, Massachusetts
• 90% Of Chilean Children With Autism Have Medical Comorbidities
• The Telehealth Factor: Most Popular OPEN MINDS Program Profiles Of 2025
• Ethical AI In Behavioral Health: Practical Use Cases That Work
• Private Equity Firms Acquired More Than 500 Autism Centers Between 2015 & 2024
• Multiple Vail Resorts Mountain Communities Receive Combined $3.2 Million Investment For Mental Health & Substance Use Service
• Turnover & Staffing Remain Key Concerns For I/DD Direct Support Professional Workforce
• Whose Evidence For Autism?
• Aetna Expands Mental Health Leadership With Dedicated Neurodiversity Support Program
• Canadian Childhood, Youth Autism Prevalence Reaches 2.25% In 2024
• Shasta Family YMCA Opens Shasta STRIDE Daily Program For Adults With Developmental Disabilities In Redding, California
• AI Autism Diagnostic Software Tool Shortened Time To Diagnosis To 39 Days
• Bristol-Myers Squibb Targets Autism Irritability With New Phase 3 Drug Trial
• IDD Navigator Platform Supports More Than 10,000 Users Since Launch
• ECM For Autism By Easterseals Southern California: An OPEN MINDS Program Profile

See All

90% Of Chilean Children With Autism Have Medical Comorbidities

About 90% of children with autism in Chile have at least one medical comorbidity. More than half had insomnia (61%) or were overweight (52%). About 28% had allergic rhinitis or atopic dermatitis, and 27% had constipation. Researchers analyzed a retrospective chart review of 544 children diagnosed with autism between 2015 and 2023 at a specialized pediatric neurodevelopmental center in Chile. The children’s comorbid medical conditions were identified through standardized caregiver interviews, clinical examination, body measurements,… Read

• Young Adults With Autism At Higher Risk Of Cardiometabolic Conditions
• Cornell University Receives $5.1 Million Grant To Fund Autism Research Center
• Evidence Base Is Weak For Complementary, Alternative & Integrative Autism Treatments, Platform Launched To Collect Additional Data
• Georgia Proposes Changes To Its HCBS Waiting List For Those With I/DD
• Whose Evidence?

To sign-up for monthly Autism & I/DD Services alerts, you must be signed in to your account.